Jaguar Health (JAGX) Times Interest Earned (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Times Interest Earned of $5.9 for Q1 2026, up 134.23% year-over-year from $2.52 in Q1 2025, and up 109.35% quarter-over-quarter from -$63.03 in Q4 2025.
Jaguar Health (JAGX) Times Interest Earned (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Times Interest Earned for 13 consecutive years, with $5.9 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 134.23% year-over-year to $5.9; the TTM figure through Mar 2026 stood at -$15.23 (up 73.99% YoY), while the FY2025 annual figure was -$25.18, down 7542.52% from the prior year.
- Times Interest Earned climbed to $5.9 in Q1 2026 per JAGX's latest filing, from -$63.03 in the prior quarter.
- Across five years, Times Interest Earned topped out at $5.9 in Q1 2026 and bottomed at -$74.15 in Q4 2024.
- Historically, Times Interest Earned has averaged -$13.83 across 5 years, with a median of -$3.9 in 2024.
- Annual changes were most pronounced in 2022 — Times Interest Earned surged 147.28% — and 2023, when it plunged 1293.67%.
- Jaguar Health's Times Interest Earned stood at $4.49 in 2022, then slumped by 1293.67% to -$53.6 in 2023, then sank by 38.36% to -$74.15 in 2024, then gained by 15.0% to -$63.03 in 2025, then surged by 109.35% to $5.9 in 2026.
- Business Quant data shows JAGX's Times Interest Earned at $5.9 in Q1 2026, -$63.03 in Q4 2025, and -$3.97 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 14.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.90 |
| Dec 31, 2025 | -63.03 |
| Sep 30, 2025 | -3.97 |
| Jun 30, 2025 | -3.84 |
| Mar 31, 2025 | -17.22 |
| Dec 31, 2024 | -74.15 |
| Sep 30, 2024 | -4.04 |
| Jun 30, 2024 | -3.90 |
| Mar 31, 2024 | -1.48 |
| Dec 31, 2023 | -53.60 |
| Sep 30, 2023 | -4.50 |
| Jun 30, 2023 | -2.35 |
| Mar 31, 2023 | -4.51 |
| Dec 31, 2022 | 4.49 |
| Sep 30, 2022 | -3.62 |
| Jun 30, 2022 | -2.55 |
| Mar 31, 2022 | -2.80 |
| Dec 31, 2021 | 1.82 |
| Sep 30, 2021 | -4.59 |
| Jun 30, 2021 | -5.76 |